C -(4-Methyl-thiazol-2-yl)-methylamine; dihydrochloride, 95.0%, 1g

4-chloro-3-nitrophenyl isocyanate, 95.0%, 5g

6-Bromoimidazo[1,2-a]pyrazin-2-amine, 95.0%, 10g

3-CYANO-N-(1,3-DIPHENYL-1H-PYRAZOL-5-YL)BENZAMIDE, 95%, 1g

1-(3-FLUOROPHENYL)CYCLOPENT-3-ENOL, 95.0%, 1g

Zinc EDTA, min 96%, pour la synthèse, 250 g, emballage plastique.

Tert-butyl 3-(cyanomethyl)-3-hydroxyazetidine-1-carboxylate, 98%, 100mg

5-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE, 95.0%, 1g

2,6-Dihydroxyanthracene>95.0%(GC)1g

3-(3-bromophenyl)-4-methyl-4,5-dihydro-1H-1,2,4-triazole-5-thione, 95+%, 1g

(S)-(+)-1-(2-Chlorophenyl)-1,2-ethanediol, 95.0%, 5g

1-BENZYL-3-(BENZYLOXY)-1,2,5,6-TETRAHYDROPYRIDINE, 95.0%, 5g

1-methyl-6-oxopiperidine-3-carboxylic acid, 95.0%, 250mg